Imaging Dye for Surgery to Find Solid Tumors
Part of Cancer clinical trials.
This study tests a new injectable dye (NC527-X) that helps surgeons see tumors better during surgery. The dye glows under special light, making it easier to find and remove cancer tissue completely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor (any cancer except brain tumors) diagnosed by imaging or biopsy and need surgery
- You are 18 years or older and in good overall health (ECOG score 0–1, meaning you can do most daily activities)
- Your blood counts, liver, and kidney function are normal or near-normal
- You have no serious heart problems, active infections, or HIV/hepatitis
- You agree to use effective birth control during the trial and for 3 months after the injection
- You have not had similar imaging dyes, other clinical trials, live vaccines, or major surgery in the past month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This study uses a special camera to look at solid tumors from inside the body during an operation. It tests whether “live” tumor imaging (using a medicine called fluorescein) can be safely performed in people with certain solid cancers.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new imaging technique that uses a special dye and light to help surgeons see exactly where the tumor ends during breast cancer surgery, so they can remove the whole tumor while sparing healthy tissue. It may help reduce the chance of leaving cancer cells behind.
This trial tests whether a fluorescent dye applied to tissue during surgery helps doctors see tumors and check if the tumor removal is complete. If you have a solid tumor and are scheduled for surgery, this study may improve the precision of your operation.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.